Crispr Therapeutics shares owned by Gables Capital Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Gables Capital Management
from 13F filings
Historical chart of Gables Capital Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Gables Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Gables Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $190k | 4.0k | 47.57 |
More positions owned by Gables Capital Management
Home Depot (HD)
View all positions for Gables Capital Management